We are live on ! Find out more
EPFB

Employees Provident Fund Board Portfolio holdings

AUM $17.4B
1-Year Est. Return 49.08%
This Fund
S&P 500
This Quarter Est. Return
+1.2%
1 Year Est. Return
+49.08%
3 Year Est. Return
+125.51%
5 Year Est. Return
+167.05%
10 Year Est. Return
+526.03%
AUM
$3.49B
AUM Growth
+$66.7M
Cap. Flow
+$24.7M
Cap. Flow %
0.71%
Top 10 Hldgs %
43.52%
Holding
55
New
3
Increased
22
Reduced
19
Closed
5
Avg Time Held
8.3 quarters
Top 10 Avg Time Held
8.4 quarters
Top 20 Avg Time Held
9 quarters

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$62.4M
2
EOG icon
EOG Resources
EOG
+$42M
3
NVDA icon
NVIDIA
NVDA
+$38.2M
4
META icon
Meta Platforms (Facebook)
META
+$37.9M
5
XOM icon
ExxonMobil
XOM
+$31.2M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Financials 24.56%
3 Energy 16.17%
4 Healthcare 10.02%
5 Consumer Staples 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ABT icon
51
Abbott
ABT
$170B
– –
-382,931
Closed -$17M –
BMY icon
52
Bristol-Myers Squibb
BMY
$122B
– –
-678,000
Closed -$36.9M –
FDX icon
53
FedEx
FDX
$69B
– –
-47,482
Closed -$9.27M –
CELG
54
DELISTED
Celgene Corp
CELG
– –
-411,143
Closed -$51.2M –

Similar funds

Employees Provident Fund Board's Q2 2017 Portfolio in Review

As of Q2 2017, Employees Provident Fund Board held 55 positions worth $3.49B, up 1.9% from $3.43B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Employees Provident Fund Board's Q2 2017 filing shows 3 new, 22 increased, 19 reduced and 5 closed positions. Its largest new stake was Bank of America: 2,676,283 shares worth $64.9M. The largest sale was Gilead Sciences, an estimated $91.3M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Energy.

  • Employees Provident Fund Board's largest Q2 2017 buy was Bank of America: 2,676,283 shares worth $64.9M.
  • Employees Provident Fund Board added most to EOG Resources in Q2 2017, an estimated $42M increase.
  • Employees Provident Fund Board's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $91.3M.
  • Employees Provident Fund Board fully exited Celgene Corp in Q2 2017, selling an estimated $51.2M.
  • Employees Provident Fund Board's ten largest holdings make up 44% of its $3.49B portfolio in Q2 2017.
  • Employees Provident Fund Board opened 3 new positions and closed 5 in Q2 2017.
  • Employees Provident Fund Board's portfolio value rose 1.9% quarter-over-quarter to $3.49B.

Based on Employees Provident Fund Board's 13F filing for Q2 2017, filed 18 Mar 2026.